Stockreport

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference [Yahoo! Finance]

Pliant Therapeutics, Inc.  (PLRX) 
PDF company, advancing internal oncology programs and a targeted siRNA delivery platform while evaluating potential in-licensing or acquisition opportunities. Early Phase [Read more]